p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

FGFR signalling is one of the most prominent pathways involved in cell growth and development as well as cancer progression. FGFR1 amplification occurs in approximately 20% of all squamous cell lung carcinomas (SCC), a predominant subtype of non-small cell lung carcinoma (NSCLC), indicating FGFR as...

Full description

Bibliographic Details
Main Authors: Izabela Zarczynska, Monika Gorska-Arcisz, Alexander Jorge Cortez, Katarzyna Aleksandra Kujawa, Agata Małgorzata Wilk, Andrzej Cezary Skladanowski, Aleksandra Stanczak, Monika Skupinska, Maciej Wieczorek, Katarzyna Marta Lisowska, Rafal Sadej, Kamila Kitowska
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Cells
Subjects:
FGFR
p38
acquired resistance
lung cancer
Online Access:https://www.mdpi.com/2073-4409/10/12/3363

Internet

https://www.mdpi.com/2073-4409/10/12/3363

Similar Items